FDA Approves Trial
Ian Hogg, YFALS Ambassador
Secure funding, develop potential treatments, end ALS
Review: Controversies and priorities in amytrophic lateral sclerosis
WEBINAR LIVE 6/25/13 - Perspectives from Robert Bestow (MND Scotland) and Robert...
90 mins on Stem Cell Clinical Trials (Recorded 5/8/13)
Co-hosts: Rob Goldstein (TDI) & Dr. Yael Gothelf (BrainStorm) discuss current an...
TDI and Gladstone Join Forces
Partners will leverage Nobel Prize winning technology to identify potential trea...
Looking for a clinical trial?
Our database is unbiased, international and updated daily.
May Update from TDI
Not registered with TDI? Click here to see our latest e-update.
Craft Brewers Unite to End ALS
30+ craft brewers to donate sales of special brews this summer to ALS TDI
In The Spotlight
Diaphragm pacing explained
SUNY's Kirsten Gruis MD talks about the NeuRx DPS including the upcoming trial
A Go for anti-NogoA
AP-HP's Pierre-François Pradat MD PhD talks GSK's ozanezumab, now at phase II
A pain reliever for pALS?
An upcoming trial asks whether mexiletine can help reduce muscle cramps in pALS.